Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Kari Miller
An effective strategy requires recruiting qualified personnel familiar with the process and technology
Dario Lirio
Modernization is critical to enhance patient experience and boost clinical trial productivity
Alexander Khomich
Healthcare software opens up opportunities for clinics in both management and patient care
Gary Shorter
Pharma needs to adapt and evolve with the changing environment of life science data
Etienne Nichols
Quality management system regulation explained

More Features

FDA Compliance News
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains
An invite from Alcon Laboratories
Intended to harmonize domestic and international requirements

More News

Quality Digest

FDA Compliance

Study Identifies Pharmaceutical Launch Best Practices

Published: Tuesday, May 24, 2005 - 22:00

A recent benchmarking study examines best practices in pharmaceutical launches, and includes case studies and insights from some of the industry’s biggest companies.The study, performed by Best Practices LLC, includes best practices from Merck & Co., Eli Lilly & Co., Wyeth, GlaxoSmithKline Inc., Novartis, Johnson & Johnson and AstraZeneca. “Best Practices in Global Pharmaceutical Launches” includes:
  • Analysis of the multiyear marketing launch investment and expense patterns of successful products
  • Profiles of leading pharmaceutical companies’ approaches to structuring global marketing organizations
  • Identification of best management practices employed during key launch activities
  • Key lessons learned in planning and coordinating successful global product launches

The leading practices, managerial insights and benchmark metrics in the report are drawn from in-depth surveys and interviews with more than 26 executives at leading pharmaceutical companies. The project team used the launches of 12 pharmaceutical products, including Zoloft, Paxil, Cardizem, Fosamax and Lipitor, to illustrate some of the problems the companies faced.

For more information, visit www3.best-in-class.com.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.